CN Stock MarketDetailed Quotes

601607 Shanghai Pharmaceuticals Holding

Watchlist
  • 18.78
  • +0.34+1.84%
Market Closed Jun 7 15:00 CST
69.55BMarket Cap18.34P/E (TTM)

Shanghai Pharmaceuticals Holding Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
11.09%30.04B
11.37%30.52B
14.80%29.26B
17.38%31.34B
-26.18%27.04B
22.38%27.4B
10.54%25.49B
16.54%26.7B
65.70%36.63B
0.42%22.39B
Transactional financial assets
-35.54%7.14B
5.60%10.15B
-9.37%11.4B
7.90%11.44B
--11.07B
--9.61B
--12.58B
--10.6B
----
----
Notes receivable and accounts receivable
8.73%82.94B
9.16%74.84B
5.44%77.43B
18.91%78.82B
18.01%76.28B
15.45%68.56B
20.11%73.43B
12.82%66.29B
16.43%64.64B
11.97%59.39B
-Notes receivable
21.70%1.69B
6.06%1.91B
7.63%1.27B
16.06%1.41B
18.96%1.39B
40.72%1.8B
352.47%1.18B
330.06%1.21B
385.01%1.17B
340.17%1.28B
-Accounts receivable
8.49%81.25B
9.25%72.93B
5.40%76.16B
18.96%77.41B
18.00%74.89B
14.89%66.76B
18.69%72.25B
11.29%65.08B
14.82%63.47B
10.17%58.11B
Other receivables (including interest and dividends)
20.19%2.96B
31.32%3.38B
23.00%2.73B
13.09%3.53B
13.14%2.46B
6.44%2.57B
-8.04%2.22B
4.34%3.12B
-15.34%2.18B
20.39%2.42B
-Dividend receivable
342.40%239.15M
339.48%239.07M
5,027.82%391.14M
1,834.68%497M
-10.00%54.06M
--54.4M
-59.84%7.63M
--25.69M
37.20%60.06M
----
Advance payment
28.23%7.2B
-17.52%3.19B
86.54%5.75B
14.80%3.66B
62.92%5.62B
57.36%3.87B
-21.99%3.08B
23.10%3.19B
-32.35%3.45B
2.84%2.46B
Inventories
5.26%33.84B
6.28%36.62B
23.62%35.05B
19.42%33.15B
26.36%32.15B
27.14%34.46B
17.44%28.35B
18.33%27.76B
6.91%25.44B
12.52%27.1B
Receivable financing
49.01%2.31B
42.57%2.32B
35.04%1.94B
7.52%1.56B
-3.63%1.55B
0.52%1.63B
-38.41%1.44B
-33.61%1.45B
-33.84%1.61B
-34.86%1.62B
Non-current assets due within one year
-66.77%53.72M
-58.29%77.42M
38.10%92.99M
18.48%156.64M
33.13%161.66M
46.73%185.62M
8.87%67.34M
109.59%132.21M
17.52%121.43M
20.11%126.51M
Other current assets
10.67%921.44M
8.93%1.33B
20.50%964.47M
45.52%1.12B
4.07%832.59M
23.32%1.22B
-10.77%800.38M
-20.41%772.57M
-20.05%800.05M
-14.22%987.69M
Total current assets
6.51%167.41B
8.64%162.43B
11.63%164.63B
17.69%164.78B
16.54%157.17B
28.34%149.51B
24.97%147.47B
22.90%140.01B
19.75%134.87B
8.30%116.49B
Non Current assets
Other equity investment
25.06%66.12M
-45.40%55.42M
14.62%53.8M
8.31%56.38M
-0.25%52.87M
38.28%101.49M
-8.30%46.93M
2.78%52.06M
10.68%53.01M
122.05%73.39M
Other non-current financial assets
1.37%2.19B
2.44%2.2B
58.89%2.12B
57.06%2.17B
63.32%2.16B
54.30%2.14B
-7.18%1.34B
22.66%1.38B
16.34%1.32B
41.93%1.39B
Investment real estate
48.93%336.48M
27.70%314.67M
45.25%298.04M
18.54%240.06M
9.31%225.93M
15.51%246.42M
-11.82%205.19M
-15.42%202.51M
-10.23%206.69M
-9.34%213.32M
Long-term equity investment
-8.99%8.55B
-9.54%8.35B
-11.69%8.55B
-10.65%8.58B
-0.43%9.4B
1.76%9.23B
3.76%9.69B
3.86%9.6B
10.27%9.44B
36.42%9.07B
Long term receivable account
10.47%225.74M
7.37%227.94M
-13.18%199.09M
1.99%200.86M
-5.63%204.35M
7.36%212.3M
-10.82%229.32M
-16.55%196.94M
41.17%216.55M
16.42%197.74M
Fixed assets
----
----
----
12.67%11.31B
----
10.06%11.54B
----
-2.33%10.04B
----
-0.06%10.48B
Constru in process
----
----
----
2.00%3.47B
----
-4.69%2.78B
----
49.79%3.4B
----
67.75%2.91B
Productive biological assets
0.61%135.97M
-2.74%133.43M
-66.53%133.93M
-66.29%135.25M
-66.40%135.14M
-65.92%137.19M
-1.38%400.13M
-1.15%401.25M
-1.48%402.2M
-0.80%402.57M
Intangible assets
-3.72%5.88B
-3.10%6.05B
2.52%5.99B
2.72%6.12B
2.73%6.11B
3.22%6.24B
14.69%5.84B
19.19%5.96B
19.40%5.95B
16.44%6.05B
Development expenditure
-9.20%306.87M
-9.37%310.51M
20.51%376.21M
28.06%363.92M
39.57%337.97M
32.16%342.61M
80.26%312.19M
45.81%284.18M
8.29%242.15M
15.82%259.23M
Goodwill
0.49%11.39B
0.51%11.39B
1.29%11.38B
1.31%11.39B
0.83%11.33B
0.86%11.34B
-0.37%11.24B
-0.39%11.24B
0.89%11.24B
-0.91%11.24B
Long deferred expense
-2.58%460.97M
2.65%474.71M
33.10%509.53M
33.41%517.07M
12.83%473.16M
7.77%462.44M
0.72%382.83M
6.68%387.57M
9.15%419.37M
3.32%429.12M
Deferred tax assets
20.49%1.87B
11.87%1.72B
10.07%1.56B
12.14%1.6B
13.85%1.55B
12.23%1.53B
-2.76%1.41B
0.40%1.43B
-3.05%1.36B
0.60%1.37B
Usufruct assets
7.94%2.07B
14.97%2.15B
-2.14%1.87B
-3.96%1.92B
-1.57%1.92B
-6.21%1.87B
3.62%1.91B
4.19%2B
0.75%1.95B
-0.01%1.99B
Other non current assets
-4.70%384.8M
-0.70%440.69M
-13.75%376.22M
-17.28%469.15M
-45.93%403.79M
-48.21%443.8M
1.74%436.2M
21.37%567.17M
111.69%746.74M
118.32%856.9M
Total non current assets
2.35%50.01B
1.89%49.54B
2.92%48.52B
2.97%48.54B
3.63%48.87B
3.58%48.62B
4.10%47.14B
5.93%47.14B
8.63%47.16B
12.78%46.94B
Total assets
5.52%217.42B
6.98%211.97B
9.52%213.15B
13.98%213.32B
13.19%206.04B
21.23%198.13B
19.18%194.62B
18.13%187.15B
16.66%182.02B
9.55%163.44B
Liabilities
Current liabilities
Short term loan
15.76%37.41B
28.14%35.56B
19.68%35.08B
16.29%33.72B
17.92%32.32B
23.26%27.75B
27.63%29.31B
33.20%29B
25.90%27.41B
11.79%22.51B
Notes payable and accounts payable
7.18%57.35B
5.95%54.63B
19.68%58.91B
25.47%56.16B
24.83%53.51B
22.79%51.57B
12.33%49.22B
9.25%44.76B
3.88%42.87B
11.12%42B
-Notes payable
1.37%6.29B
12.68%6.72B
39.31%6.65B
39.60%6.11B
39.63%6.2B
25.12%5.96B
3.98%4.77B
-5.41%4.38B
-10.70%4.44B
-3.37%4.76B
-Accounts payable
7.94%51.07B
5.07%47.92B
17.57%52.26B
23.93%50.05B
23.12%47.31B
22.49%45.6B
13.31%44.45B
11.12%40.39B
5.87%38.43B
13.30%37.23B
Contract liabilities
-18.58%1.6B
-12.13%1.97B
-18.40%973.57M
17.92%1.44B
148.70%1.97B
71.09%2.24B
-1.15%1.19B
-15.87%1.22B
-19.53%790.47M
0.01%1.31B
Salaries payable
13.06%1.3B
12.88%1.78B
16.45%1.4B
27.87%1.41B
19.73%1.15B
10.29%1.58B
14.52%1.2B
15.04%1.11B
19.64%963.57M
12.49%1.43B
Taxs payable
-3.06%1.23B
-15.52%1.22B
2.36%1.04B
1.89%1.3B
-0.22%1.27B
-14.88%1.44B
0.62%1.02B
24.73%1.27B
28.10%1.28B
14.52%1.69B
Other payable (including interest and dividends)
5.61%16.62B
8.95%17.95B
10.14%15.92B
30.82%19.87B
31.45%15.74B
26.12%16.47B
9.39%14.45B
6.13%15.19B
-2.10%11.97B
7.57%13.06B
-Dividend payable
-11.81%245.17M
-33.77%247.13M
54.63%319.74M
37.55%2.6B
-23.38%278.02M
9.24%373.13M
-36.48%206.77M
20.39%1.89B
79.13%362.83M
83.51%341.55M
Non current liabilities due within one year
67.77%3.57B
-8.80%2.96B
60.71%2.94B
259.91%4.23B
176.54%2.13B
458.28%3.25B
-52.00%1.83B
-82.74%1.18B
-91.47%769.89M
-93.51%582.04M
Other current liabilities
-0.55%6.18B
-1.46%6.29B
-32.70%6.17B
-0.20%6.2B
-32.23%6.21B
-30.84%6.38B
52.12%9.17B
23.64%6.21B
82.42%9.17B
83.96%9.23B
Total current liabilities
9.60%125.27B
10.55%122.37B
14.00%122.43B
24.41%124.34B
20.05%114.3B
20.55%110.69B
15.36%107.4B
8.24%99.94B
3.28%95.21B
4.19%91.82B
Current liabilities
Long term loan
-22.98%6.62B
-7.57%5.79B
13.21%7.49B
-10.81%6.87B
21.79%8.6B
-12.55%6.26B
-2.75%6.61B
129.30%7.7B
297.39%7.06B
504.50%7.16B
Long term salaries pay
-2.50%37.1M
-0.07%38.88M
2.12%38.35M
0.98%38.79M
2.13%38.05M
-0.24%38.91M
-0.22%37.55M
-3.75%38.41M
-16.49%37.26M
-15.95%39.01M
Estimate liabilities
49.46%35.88M
65.08%39.59M
-46.38%26.8M
-48.30%26.26M
3.28%24.01M
3.16%23.98M
49.90%49.98M
97.13%50.78M
-9.77%23.24M
-9.77%23.24M
Deferred tax liabilities
1.56%998.51M
-3.18%1.02B
-20.84%928.28M
-15.56%985.58M
-0.05%983.17M
5.05%1.05B
16.13%1.17B
12.63%1.17B
-5.04%983.61M
19.99%998.77M
Long term deferred income
12.38%633.16M
18.50%633.48M
17.08%538.35M
13.39%562.76M
-75.38%563.42M
-77.24%534.58M
-79.65%459.8M
-78.70%496.28M
-0.09%2.29B
5.62%2.35B
Lease liabilities
8.02%1.51B
19.09%1.55B
-23.35%1.31B
-9.82%1.32B
-1.43%1.4B
-9.25%1.3B
19.85%1.71B
0.96%1.47B
-1.98%1.42B
-4.45%1.43B
Other non current liabilities
-12.57%207.9M
-10.16%202.4M
-9.08%232.58M
-12.59%221.87M
-19.43%237.79M
-1.05%225.29M
26.39%255.82M
11.12%253.83M
129.62%295.12M
57.41%227.69M
Total non current liabilities
-15.14%10.06B
-1.77%9.27B
-0.29%10.57B
-12.66%10.04B
-4.64%11.85B
-24.74%9.44B
-12.22%10.6B
30.59%11.49B
74.95%12.43B
98.75%12.54B
Total liabilities
7.27%135.33B
9.58%131.65B
12.71%133B
20.59%134.38B
17.20%126.15B
15.10%120.13B
12.19%118B
10.18%111.43B
8.41%107.64B
10.51%104.37B
Shareholders equity
Paid-in capital
0.13%3.7B
0.16%3.7B
0.19%3.7B
0.18%3.7B
0.08%3.7B
30.10%3.7B
30.06%3.7B
30.06%3.7B
30.03%3.7B
0.00%2.84B
Capital reserve funds
0.25%29.19B
0.31%29.19B
-0.41%29.17B
-0.14%29.16B
-0.19%29.11B
81.06%29.1B
82.89%29.29B
82.48%29.21B
83.38%29.17B
1.09%16.07B
Surplus reserve funds
6.86%2.31B
6.86%2.31B
8.35%2.16B
8.35%2.16B
8.35%2.16B
8.35%2.16B
9.11%1.99B
9.11%1.99B
9.11%1.99B
9.11%1.99B
Retained profit
4.02%35.36B
4.13%33.82B
7.29%34.02B
6.80%32.83B
13.90%34B
13.57%32.48B
12.55%31.71B
12.78%30.74B
9.84%29.85B
14.15%28.6B
Other composite income
-24.66%-501M
-33.60%-496.09M
-5.68%-538.76M
-62.42%-498.24M
-117.35%-401.88M
-157.16%-371.32M
-159.54%-509.78M
-42.91%-306.76M
42.12%-184.9M
45.60%-144.39M
Shareholders equity without minority interests
2.18%70.06B
2.18%68.52B
3.53%68.51B
3.11%67.36B
6.27%68.57B
35.87%67.06B
36.00%66.17B
36.91%65.33B
36.04%64.52B
8.83%49.36B
Minority interests
6.28%12.02B
7.88%11.8B
11.43%11.63B
11.48%11.58B
14.78%11.31B
12.70%10.94B
10.44%10.44B
8.53%10.39B
5.88%9.86B
3.42%9.71B
Total shareholder equity
2.76%82.09B
2.98%80.33B
4.60%80.14B
4.26%78.94B
7.40%79.88B
32.06%78B
31.84%76.62B
32.17%75.72B
31.09%74.38B
7.90%59.07B
Total liabilityies and equity
5.52%217.42B
6.98%211.97B
9.52%213.15B
13.98%213.32B
13.19%206.04B
21.23%198.13B
19.18%194.62B
18.13%187.15B
16.66%182.02B
9.55%163.44B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds 11.09%30.04B11.37%30.52B14.80%29.26B17.38%31.34B-26.18%27.04B22.38%27.4B10.54%25.49B16.54%26.7B65.70%36.63B0.42%22.39B
Transactional financial assets -35.54%7.14B5.60%10.15B-9.37%11.4B7.90%11.44B--11.07B--9.61B--12.58B--10.6B--------
Notes receivable and accounts receivable 8.73%82.94B9.16%74.84B5.44%77.43B18.91%78.82B18.01%76.28B15.45%68.56B20.11%73.43B12.82%66.29B16.43%64.64B11.97%59.39B
-Notes receivable 21.70%1.69B6.06%1.91B7.63%1.27B16.06%1.41B18.96%1.39B40.72%1.8B352.47%1.18B330.06%1.21B385.01%1.17B340.17%1.28B
-Accounts receivable 8.49%81.25B9.25%72.93B5.40%76.16B18.96%77.41B18.00%74.89B14.89%66.76B18.69%72.25B11.29%65.08B14.82%63.47B10.17%58.11B
Other receivables (including interest and dividends) 20.19%2.96B31.32%3.38B23.00%2.73B13.09%3.53B13.14%2.46B6.44%2.57B-8.04%2.22B4.34%3.12B-15.34%2.18B20.39%2.42B
-Dividend receivable 342.40%239.15M339.48%239.07M5,027.82%391.14M1,834.68%497M-10.00%54.06M--54.4M-59.84%7.63M--25.69M37.20%60.06M----
Advance payment 28.23%7.2B-17.52%3.19B86.54%5.75B14.80%3.66B62.92%5.62B57.36%3.87B-21.99%3.08B23.10%3.19B-32.35%3.45B2.84%2.46B
Inventories 5.26%33.84B6.28%36.62B23.62%35.05B19.42%33.15B26.36%32.15B27.14%34.46B17.44%28.35B18.33%27.76B6.91%25.44B12.52%27.1B
Receivable financing 49.01%2.31B42.57%2.32B35.04%1.94B7.52%1.56B-3.63%1.55B0.52%1.63B-38.41%1.44B-33.61%1.45B-33.84%1.61B-34.86%1.62B
Non-current assets due within one year -66.77%53.72M-58.29%77.42M38.10%92.99M18.48%156.64M33.13%161.66M46.73%185.62M8.87%67.34M109.59%132.21M17.52%121.43M20.11%126.51M
Other current assets 10.67%921.44M8.93%1.33B20.50%964.47M45.52%1.12B4.07%832.59M23.32%1.22B-10.77%800.38M-20.41%772.57M-20.05%800.05M-14.22%987.69M
Total current assets 6.51%167.41B8.64%162.43B11.63%164.63B17.69%164.78B16.54%157.17B28.34%149.51B24.97%147.47B22.90%140.01B19.75%134.87B8.30%116.49B
Non Current assets
Other equity investment 25.06%66.12M-45.40%55.42M14.62%53.8M8.31%56.38M-0.25%52.87M38.28%101.49M-8.30%46.93M2.78%52.06M10.68%53.01M122.05%73.39M
Other non-current financial assets 1.37%2.19B2.44%2.2B58.89%2.12B57.06%2.17B63.32%2.16B54.30%2.14B-7.18%1.34B22.66%1.38B16.34%1.32B41.93%1.39B
Investment real estate 48.93%336.48M27.70%314.67M45.25%298.04M18.54%240.06M9.31%225.93M15.51%246.42M-11.82%205.19M-15.42%202.51M-10.23%206.69M-9.34%213.32M
Long-term equity investment -8.99%8.55B-9.54%8.35B-11.69%8.55B-10.65%8.58B-0.43%9.4B1.76%9.23B3.76%9.69B3.86%9.6B10.27%9.44B36.42%9.07B
Long term receivable account 10.47%225.74M7.37%227.94M-13.18%199.09M1.99%200.86M-5.63%204.35M7.36%212.3M-10.82%229.32M-16.55%196.94M41.17%216.55M16.42%197.74M
Fixed assets ------------12.67%11.31B----10.06%11.54B-----2.33%10.04B-----0.06%10.48B
Constru in process ------------2.00%3.47B-----4.69%2.78B----49.79%3.4B----67.75%2.91B
Productive biological assets 0.61%135.97M-2.74%133.43M-66.53%133.93M-66.29%135.25M-66.40%135.14M-65.92%137.19M-1.38%400.13M-1.15%401.25M-1.48%402.2M-0.80%402.57M
Intangible assets -3.72%5.88B-3.10%6.05B2.52%5.99B2.72%6.12B2.73%6.11B3.22%6.24B14.69%5.84B19.19%5.96B19.40%5.95B16.44%6.05B
Development expenditure -9.20%306.87M-9.37%310.51M20.51%376.21M28.06%363.92M39.57%337.97M32.16%342.61M80.26%312.19M45.81%284.18M8.29%242.15M15.82%259.23M
Goodwill 0.49%11.39B0.51%11.39B1.29%11.38B1.31%11.39B0.83%11.33B0.86%11.34B-0.37%11.24B-0.39%11.24B0.89%11.24B-0.91%11.24B
Long deferred expense -2.58%460.97M2.65%474.71M33.10%509.53M33.41%517.07M12.83%473.16M7.77%462.44M0.72%382.83M6.68%387.57M9.15%419.37M3.32%429.12M
Deferred tax assets 20.49%1.87B11.87%1.72B10.07%1.56B12.14%1.6B13.85%1.55B12.23%1.53B-2.76%1.41B0.40%1.43B-3.05%1.36B0.60%1.37B
Usufruct assets 7.94%2.07B14.97%2.15B-2.14%1.87B-3.96%1.92B-1.57%1.92B-6.21%1.87B3.62%1.91B4.19%2B0.75%1.95B-0.01%1.99B
Other non current assets -4.70%384.8M-0.70%440.69M-13.75%376.22M-17.28%469.15M-45.93%403.79M-48.21%443.8M1.74%436.2M21.37%567.17M111.69%746.74M118.32%856.9M
Total non current assets 2.35%50.01B1.89%49.54B2.92%48.52B2.97%48.54B3.63%48.87B3.58%48.62B4.10%47.14B5.93%47.14B8.63%47.16B12.78%46.94B
Total assets 5.52%217.42B6.98%211.97B9.52%213.15B13.98%213.32B13.19%206.04B21.23%198.13B19.18%194.62B18.13%187.15B16.66%182.02B9.55%163.44B
Liabilities
Current liabilities
Short term loan 15.76%37.41B28.14%35.56B19.68%35.08B16.29%33.72B17.92%32.32B23.26%27.75B27.63%29.31B33.20%29B25.90%27.41B11.79%22.51B
Notes payable and accounts payable 7.18%57.35B5.95%54.63B19.68%58.91B25.47%56.16B24.83%53.51B22.79%51.57B12.33%49.22B9.25%44.76B3.88%42.87B11.12%42B
-Notes payable 1.37%6.29B12.68%6.72B39.31%6.65B39.60%6.11B39.63%6.2B25.12%5.96B3.98%4.77B-5.41%4.38B-10.70%4.44B-3.37%4.76B
-Accounts payable 7.94%51.07B5.07%47.92B17.57%52.26B23.93%50.05B23.12%47.31B22.49%45.6B13.31%44.45B11.12%40.39B5.87%38.43B13.30%37.23B
Contract liabilities -18.58%1.6B-12.13%1.97B-18.40%973.57M17.92%1.44B148.70%1.97B71.09%2.24B-1.15%1.19B-15.87%1.22B-19.53%790.47M0.01%1.31B
Salaries payable 13.06%1.3B12.88%1.78B16.45%1.4B27.87%1.41B19.73%1.15B10.29%1.58B14.52%1.2B15.04%1.11B19.64%963.57M12.49%1.43B
Taxs payable -3.06%1.23B-15.52%1.22B2.36%1.04B1.89%1.3B-0.22%1.27B-14.88%1.44B0.62%1.02B24.73%1.27B28.10%1.28B14.52%1.69B
Other payable (including interest and dividends) 5.61%16.62B8.95%17.95B10.14%15.92B30.82%19.87B31.45%15.74B26.12%16.47B9.39%14.45B6.13%15.19B-2.10%11.97B7.57%13.06B
-Dividend payable -11.81%245.17M-33.77%247.13M54.63%319.74M37.55%2.6B-23.38%278.02M9.24%373.13M-36.48%206.77M20.39%1.89B79.13%362.83M83.51%341.55M
Non current liabilities due within one year 67.77%3.57B-8.80%2.96B60.71%2.94B259.91%4.23B176.54%2.13B458.28%3.25B-52.00%1.83B-82.74%1.18B-91.47%769.89M-93.51%582.04M
Other current liabilities -0.55%6.18B-1.46%6.29B-32.70%6.17B-0.20%6.2B-32.23%6.21B-30.84%6.38B52.12%9.17B23.64%6.21B82.42%9.17B83.96%9.23B
Total current liabilities 9.60%125.27B10.55%122.37B14.00%122.43B24.41%124.34B20.05%114.3B20.55%110.69B15.36%107.4B8.24%99.94B3.28%95.21B4.19%91.82B
Current liabilities
Long term loan -22.98%6.62B-7.57%5.79B13.21%7.49B-10.81%6.87B21.79%8.6B-12.55%6.26B-2.75%6.61B129.30%7.7B297.39%7.06B504.50%7.16B
Long term salaries pay -2.50%37.1M-0.07%38.88M2.12%38.35M0.98%38.79M2.13%38.05M-0.24%38.91M-0.22%37.55M-3.75%38.41M-16.49%37.26M-15.95%39.01M
Estimate liabilities 49.46%35.88M65.08%39.59M-46.38%26.8M-48.30%26.26M3.28%24.01M3.16%23.98M49.90%49.98M97.13%50.78M-9.77%23.24M-9.77%23.24M
Deferred tax liabilities 1.56%998.51M-3.18%1.02B-20.84%928.28M-15.56%985.58M-0.05%983.17M5.05%1.05B16.13%1.17B12.63%1.17B-5.04%983.61M19.99%998.77M
Long term deferred income 12.38%633.16M18.50%633.48M17.08%538.35M13.39%562.76M-75.38%563.42M-77.24%534.58M-79.65%459.8M-78.70%496.28M-0.09%2.29B5.62%2.35B
Lease liabilities 8.02%1.51B19.09%1.55B-23.35%1.31B-9.82%1.32B-1.43%1.4B-9.25%1.3B19.85%1.71B0.96%1.47B-1.98%1.42B-4.45%1.43B
Other non current liabilities -12.57%207.9M-10.16%202.4M-9.08%232.58M-12.59%221.87M-19.43%237.79M-1.05%225.29M26.39%255.82M11.12%253.83M129.62%295.12M57.41%227.69M
Total non current liabilities -15.14%10.06B-1.77%9.27B-0.29%10.57B-12.66%10.04B-4.64%11.85B-24.74%9.44B-12.22%10.6B30.59%11.49B74.95%12.43B98.75%12.54B
Total liabilities 7.27%135.33B9.58%131.65B12.71%133B20.59%134.38B17.20%126.15B15.10%120.13B12.19%118B10.18%111.43B8.41%107.64B10.51%104.37B
Shareholders equity
Paid-in capital 0.13%3.7B0.16%3.7B0.19%3.7B0.18%3.7B0.08%3.7B30.10%3.7B30.06%3.7B30.06%3.7B30.03%3.7B0.00%2.84B
Capital reserve funds 0.25%29.19B0.31%29.19B-0.41%29.17B-0.14%29.16B-0.19%29.11B81.06%29.1B82.89%29.29B82.48%29.21B83.38%29.17B1.09%16.07B
Surplus reserve funds 6.86%2.31B6.86%2.31B8.35%2.16B8.35%2.16B8.35%2.16B8.35%2.16B9.11%1.99B9.11%1.99B9.11%1.99B9.11%1.99B
Retained profit 4.02%35.36B4.13%33.82B7.29%34.02B6.80%32.83B13.90%34B13.57%32.48B12.55%31.71B12.78%30.74B9.84%29.85B14.15%28.6B
Other composite income -24.66%-501M-33.60%-496.09M-5.68%-538.76M-62.42%-498.24M-117.35%-401.88M-157.16%-371.32M-159.54%-509.78M-42.91%-306.76M42.12%-184.9M45.60%-144.39M
Shareholders equity without minority interests 2.18%70.06B2.18%68.52B3.53%68.51B3.11%67.36B6.27%68.57B35.87%67.06B36.00%66.17B36.91%65.33B36.04%64.52B8.83%49.36B
Minority interests 6.28%12.02B7.88%11.8B11.43%11.63B11.48%11.58B14.78%11.31B12.70%10.94B10.44%10.44B8.53%10.39B5.88%9.86B3.42%9.71B
Total shareholder equity 2.76%82.09B2.98%80.33B4.60%80.14B4.26%78.94B7.40%79.88B32.06%78B31.84%76.62B32.17%75.72B31.09%74.38B7.90%59.07B
Total liabilityies and equity 5.52%217.42B6.98%211.97B9.52%213.15B13.98%213.32B13.19%206.04B21.23%198.13B19.18%194.62B18.13%187.15B16.66%182.02B9.55%163.44B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg